上海百心安生物技术股份有限公司（股票代码：02185）于2026年3月5日披露2026年2月股份变动月报表，报告期自2026年2月1日至2月28日。
公告显示，截至本月末，该公司H股数量为235,703,422股，非上市外资股数量为7,713,678股，两类股份均与上月底持平。公司注册股本合计243,417,100股，报告期内未见新增发行、购回或注销行为，股本结构保持稳定。
本月内，公司没有股份期权或股权激励计划方面的授出、行使或失效记录。公告还显示，公司已确认截至2月底的公众持股量符合相关规定。
公告由执行董事兼联席公司秘书王云磬签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.